167 related articles for article (PubMed ID: 16305589)
1. Dramatic change in prescribing of hormone replacement therapy in The Netherlands after publication of the Million Women Study: a follow-up study.
Faber A; Bouvy ML; Loskamp L; van de Berg PB; Egberts TC; de Jong-van den Berg LT
Br J Clin Pharmacol; 2005 Dec; 60(6):641-7. PubMed ID: 16305589
[TBL] [Abstract][Full Text] [Related]
2. HRT use in 2001 and 2004 in The Netherlands--a world of difference.
de Jong-van den Berg LT; Faber A; van den Berg PB
Maturitas; 2006 May; 54(2):193-7. PubMed ID: 16321484
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy: patterns of use studied through British general practice computerized records.
Lawrence M; Jones L; Lancaster T; Daly E; Banks E
Fam Pract; 1999 Aug; 16(4):335-42. PubMed ID: 10493702
[TBL] [Abstract][Full Text] [Related]
4. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
[TBL] [Abstract][Full Text] [Related]
5. [Utilization of hormone replacement therapy in Spain: Trends in the period 2000-2014].
Baladé Martínez L; Montero Corominas D; Macías Saint-Gerons D
Med Clin (Barc); 2016 Oct; 147(7):287-92. PubMed ID: 27423654
[TBL] [Abstract][Full Text] [Related]
6. Treatment of menopausal symptoms in family medicine settings following the Women's Health Initiative findings.
Burg MA; Fraser K; Gui S; Grant K; Kosch SG; Nierenberg B; Oyama O; Pomm H; Sibille K; Spruill T; Swartz V;
J Am Board Fam Med; 2006; 19(2):122-31. PubMed ID: 16513900
[TBL] [Abstract][Full Text] [Related]
7. Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.
Watson J; Wise L; Green J
Eur J Clin Pharmacol; 2007 Sep; 63(9):843-9. PubMed ID: 17598097
[TBL] [Abstract][Full Text] [Related]
8. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
Lemay A
J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
[TBL] [Abstract][Full Text] [Related]
9. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
Hillman JJ; Zuckerman IH; Lee E
J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
[TBL] [Abstract][Full Text] [Related]
10. The impact of new insights and revised practice guidelines on prescribing drugs in the treatment of Type 2 diabetes mellitus.
Lub R; Denig P; van den Berg PB; Hoogenberg K; de Jong-van den Berg LT
Br J Clin Pharmacol; 2006 Dec; 62(6):660-5. PubMed ID: 16796700
[TBL] [Abstract][Full Text] [Related]
11. Significant fall in hormone replacement therapy prescription in general practice.
Lagro-Janssen A; Knufing MW; Schreurs L; van Weel C
Fam Pract; 2010 Aug; 27(4):424-9. PubMed ID: 20406789
[TBL] [Abstract][Full Text] [Related]
12. Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial.
Ness J; Aronow WS; Newkirk E; McDanel D
J Gerontol A Biol Sci Med Sci; 2005 Apr; 60(4):460-2. PubMed ID: 15933383
[TBL] [Abstract][Full Text] [Related]
13. National use of postmenopausal hormone therapy: annual trends and response to recent evidence.
Hersh AL; Stefanick ML; Stafford RS
JAMA; 2004 Jan; 291(1):47-53. PubMed ID: 14709575
[TBL] [Abstract][Full Text] [Related]
14. Trends in HRT and anti-osteoporosis medication prescribing in a European population after the WHI study.
Huot L; Couris CM; Tainturier V; Jaglal S; Colin C; Schott AM
Osteoporos Int; 2008 Jul; 19(7):1047-54. PubMed ID: 18373055
[TBL] [Abstract][Full Text] [Related]
15. Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid.
Udell JA; Fischer MA; Brookhart MA; Solomon DH; Choudhry NK
J Bone Miner Res; 2006 May; 21(5):765-71. PubMed ID: 16734392
[TBL] [Abstract][Full Text] [Related]
16. Evolving issues in the clinical and managed care settings on the management of menopause following the women's health initiative.
Lukes A
J Manag Care Pharm; 2008 Apr; 14(3 Suppl):7-13. PubMed ID: 18439061
[TBL] [Abstract][Full Text] [Related]
17. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
[TBL] [Abstract][Full Text] [Related]
18. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
Barber CA; Margolis K; Luepker RV; Arnett DK
J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy: changes in frequency and type of prescription by Dutch GPs during the last decade of the millennium.
Donker GA; Spreeuwenberg P; Bartelds AI; van der Velden K; Foets M
Fam Pract; 2000 Dec; 17(6):508-13. PubMed ID: 11120723
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy: an example of McKinlay's theory on the seven stages of medical innovation.
Wright J
J Clin Nurs; 2005 Oct; 14(9):1090-7. PubMed ID: 16164527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
